Table 1.

Patient characteristics and analytical cohorts.

	MOC		MBOT		Upper GIa		Lower GIb
Clinical and gene-expression data n = 604	333		151		65		55
Age at diagnosis (years)
Median	53		47		67		68
Range	18–95		18–91		31–85		39–89
	n	% of known	n	% of known	n	% of known	n	% of known
Stage
I	206	78%	98	95%	5	8%	8	18%
II	20	8%	2	2%	26	41%	11	25%
III	31	12%	3	3%	26	41%	15	34%
IV	7	3%	0	0%	6	10%	10	23%
Unknown	69		48		2		11
Sex
Female	333	100%	151	100%	33	51%	47	85%
Male	0	0%	0	0%	32	49%	8	15%
Grade
1	136	46%	n/a		3	5%	12	23%
2	113	38%	n/a		44	72%	32	62%
3	46	16%	n/a		14	23%	8	15%
Unknown	38		n/a		4		3
Residual disease
Nil macroscopic	145	86%	62	90%	18	82%	25	84%
Yes	24	14%	7	10%	4	18%	7	25%
Unknown	164		82		43		23

Abbreviations: MOC, mucinous ovarian carcinoma; MBOT, mucinous borderline ovarian tumor; GI, gastrointestinal.

^aPancreas cancer (n = 57); gastric cancer (n = 5); upper GI metastases, unknown primary (n = 3).

^bColorectal cancer (n = 36); appendiceal cancer (n = 15); lower GI metastases, unknown primary (n = 4).